Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-Β cytostatic program and blocks the antiproliferative effect of TGF-Β

Oncogene

Volumn 30, Issue 24, 2011, Pages 2718-2729

  Trinh, B Q ^a,b   Barengo, N ^a   Naora, H ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

cell growth; homeobox genes; Smad; Sp1; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HOMEODOMAIN PROTEIN DLX4; NERVE CELL ADHESION MOLECULE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL VIABILITY; CYTOSTASIS; DOWN REGULATION; ESCHERICHIA COLI; MITOSIS INHIBITION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR RESISTANCE;

BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; HOMEODOMAIN PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; SMAD PROTEINS, RECEPTOR-REGULATED; SMAD4 PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 79958776867     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.4     Document Type: Article

References (53)

1. Abate-Shen C. (2002). Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2: 777-785. (Pubitemid 37328912)
2. Bello-DeOcampo D, Tindall DJ. (2003). TGF-b/Smad signaling in prostate cancer. Curr Drug Targets 4: 197-207.
3. Berghorn KA, Clark-Campbell PA, Han L, McGrattan M, Weiss RS, Roberson MS. (2006). Smad6 represses Dlx3 transcriptional activity through inhibition of DNA binding. J Biol Chem 281: 20357-20367. (Pubitemid 44065810)
4. Boogerd KJ, Wong LY, Christoffels VM, Klarenbeek M, Ruijter JM, Moorman AF et al. (2008). Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of connex-in43. Cardiovasc Res 78: 485-493. (Pubitemid 351769772)
5. Chen CR, Kang Y, Siegel PM, Massague J. (2002). E2F4/5 and p107 as Smad cofactors linking the TGFb receptor to c-myc repression. Cell 110: 19-32. (Pubitemid 34874603)
6. Chiba S, Takeshita K, Imai Y, Kumano K, Kurokawa M, Masuda S et al. (2003). Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells. Proc Natl Acad Sci USA 100: 15577-15582. (Pubitemid 38021032)
7. Coletta RD, Christensen K, Reichenberger KJ, Lamb J, Micomonaco D, Huang L et al. (2004). The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci USA 101: 6478-6483. (Pubitemid 38585999)
8. Deckers M, van Dinther M, Buijs J, Que I, Lowik C, van der Pluijm G et al. (2006). The tumor suppressor Smad4 is required for transforming growth factor-b-induced epithelial-to-mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66: 2202-2209.
9. Feng XH, Derynck R. (2005). Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693. (Pubitemid 41740650)
10. Ink4B. Mol Cell 9: 133-143. (Pubitemid 34127777)
11. Ink4B transcription in response to TGF-b. EMBO J 19: 5178-5193.
12. Francis-Thickpenny KM, Richardson DM, van Ee CC, Love DR, Winship IM, Baguley BC et al. (2001). Analysis of the transforming growth factor-b functional pathway in epithelial ovarian carcinoma. Br J Cancer 85: 687-691. (Pubitemid 32929466)
13. WAF1/Cip1 promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98: 4510-4515. (Pubitemid 32295007)
14. INK4/MTS1, p18 and p19 in human cancer cell lines. Int J Cancer 68: 605-611.
15. Haga SB, Fu S, Karp JE, Ross DD, Williams DM, Hankins WD et al. (2000). BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 14: 1867-1875.
16. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E et al. (1996). DPC4, a candidate tumor suppressor at human chromosome 18q21.1. Science 271: 350-353.
17. Hara F, Samuel S, Liu J, Rosen D, Langley R, Naora H. (2007). A homeobox gene related to Drosophila Distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2. Am J Pathol 170: 1594-1606. (Pubitemid 47339304)
18. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512. (Pubitemid 28425575)
19. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E et al. (2002). Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62: 6240-6245. (Pubitemid 35244477)
20. Kang Y, Chen CR, Massague J. (2003). A self-enabling TGFb response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11: 915-926. (Pubitemid 36566314)
21. Korchynskyi O, Ten Dijke P. (2002). Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891. (Pubitemid 34968524)
22. Kusanagi K, Inoue H, Ishidou Y, Mishima H, Kawabata M, Miyazono K. (2000). Characterization of a bone morpho-genetic protein-responsive Smad-binding element. Mol Cell Biol 11: 555-565. (Pubitemid 30112165)
23. Man YG, Fu SW, Schwartz A, Pinzone JJ, Simmens SJ, Berg PE. (2005). Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 90: 241-247. (Pubitemid 40576837)
24. Massague J. (2008). TGF-b in cancer. Cell 134: 215-230.
25. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J et al. (1995). Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
26. McGinnis W, Krumlauf R. (1992). Homeobox genes and axial patterning. Cell 68: 283-302.
27. Moustakas A, Heldin CH. (2005). Non-Smad TGF-b signals. J Cell Science 118: 3573-3584.
28. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S et al. (1996). Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56: 2718-2720. (Pubitemid 26175725)
29. Naora H, Yang YQ, Montz FJ, Seidman JD, Kurman RJ, Roden RB. (2001). A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 98: 4060-4065. (Pubitemid 32249898)
30. Panganiban G, Rubenstein JL. (2002). Developmental functions of the Distal-less/Dlx homeobox genes. Development 129: 4371-4386. (Pubitemid 35203722)
31. Waf1/Cip1 regulation by transforming growth factor-b. J Biol Chem 275: 29244-29256. (Pubitemid 32043793)
32. Park GT, Morasso MI. (2002). Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes. Nucleic Acids Res 30: 515-522. (Pubitemid 34679613)
33. Petritsch C, Beug H, Balmain A, Oft M. (2000). TGF-b inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest. Genes Dev 14: 3093-3101. (Pubitemid 32015128)
34. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E et al. (2000). Compromised HOXA5 function can limit p53 expression in human breast tumors. Nature 405: 974-978. (Pubitemid 30435057)
35. Reynisdottir I, Polyak K, Iavarone A, Massague J. (1995). Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-b. Genes Dev 9: 1831-1845.
36. Samuel S, Naora H. (2005). Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer 41: 2428-2437. (Pubitemid 41540620)
37. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL et al. (1996). DPC4 gene in various tumor types. Cancer Res 56: 2527-2530. (Pubitemid 26170688)
38. Schwartz AM, Man YG, Rezaei MK, Simmens SJ, Berg PE. (2009). BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia. Mod Pathol 22: 1-6.
39. Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C. (1999). HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 19: 3051-3061. (Pubitemid 29144550)
40. Shi Y, Massague J. (2003). Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
41. Siegel PM, Massague J. (2003). Cytostatic and apoptotic actions of TGFb in homeostasis and cancer. Nat Rev Cancer 3: 807-820. (Pubitemid 37376979)
42. Takenoshita S, Hagiwara K, Gemma A, Nagashima M, Ryberg D, Lindstedt BA et al. (1997). Absence of mutations in the transforming growth factor b type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. Carcinogenesis 18: 1427-1429. (Pubitemid 28134722)
43. Takenoshita S, Mogi A, Tani M, Osawa H, Sunaga H, Kakegawa H et al. (1998). Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-b type II receptor gene in sporadic human breast cancers. Oncol Rep 5: 367-371. (Pubitemid 28100091)
44. Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. (1999). Decreased expression of transforming growth factor b receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res 5: 2520-2525. (Pubitemid 29437337)
45. Tomida S, Yanagisawa K, Koshikawa K, Yatabe Y, Mitsudomi T, Osada H et al. (2007). Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by a combined transcriptome approach. Oncogene 26: 4600-4608. (Pubitemid 47037043)
46. Tournay O, Benezra R. (1996). Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 16: 2418-2430. (Pubitemid 26123764)
47. Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N et al. (2000). Analysis of specific gene mutations in the transforming growth factor b signal transduction pathway in human ovarian cancer. Cancer Res 60: 4507-4512. (Pubitemid 32103632)
48. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG et al. (2001). Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344: 1196-1206. (Pubitemid 32319494)
49. Williams TM, Williams ME, Heaton JH, Gelehrter TD, Innis JW. (2005). Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability. Nucleic Acids Res 33: 4475-4484. (Pubitemid 41222562)
50. Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS et al. (2001). SMAD4 mutations in colorectal cancer probably occur before chromosomal instability but after divergence of the microsatellite instability pathway. Proc Natl Acad Sci USA 98: 9719-9723. (Pubitemid 32769370)
51. Yamada SD, Baldwin RL, Karlan BY. (1999). Ovarian carcinoma cell cultures are resistant to TGF-b1-mediated growth inhibition despite expression of functional receptors. Gynecol Oncol 75: 72-77. (Pubitemid 29477805)
52. Yang X, Ji X, Shi X, Cao X. (2000). Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation. J Biol Chem 275: 1065-1072. (Pubitemid 30051155)
53. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B et al. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617. (Pubitemid 128374697)